Use of intrauterine devices and risk of human immunodeficiency virus acquisition among insured women in the United States

Julia L. Marcus, Jonathan M. Snowden, Mara E. Murray Horwitz, Sengwee Toh, Casie Horgan, Rong Chen Tilney, Rajani Rajbhandari, Soowoo Back, Daniel J. Westreich

Research output: Contribution to journalArticlepeer-review

Abstract

Concerns have been raised about progestin-containing contraceptives and the risk of human immunodeficiency virus (HIV) acquisition. Based on health insurance data from women in the United States with intrauterine device (IUD) insertions during 2011-2018, there was no increased risk of incident HIV diagnosis for levonorgestrel-releasing IUDs versus copper IUDs.

Original languageEnglish (US)
Pages (from-to)2221-2223
Number of pages3
JournalClinical Infectious Diseases
Volume70
Issue number10
DOIs
StatePublished - May 6 2020

Keywords

  • Copper intrauterine devices
  • Hormone releasing intrauterine de vices
  • Human immunodeficiency virus
  • Intrauterine devices
  • Long-acting reversible contraception

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Use of intrauterine devices and risk of human immunodeficiency virus acquisition among insured women in the United States'. Together they form a unique fingerprint.

Cite this